J. Peuskens

2.5k total citations · 1 hit paper
19 papers, 1.9k citations indexed

About

J. Peuskens is a scholar working on Psychiatry and Mental health, Philosophy and Pharmacology. According to data from OpenAlex, J. Peuskens has authored 19 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 5 papers in Philosophy and 3 papers in Pharmacology. Recurrent topics in J. Peuskens's work include Schizophrenia research and treatment (14 papers), Mental Health and Psychiatry (5 papers) and Bipolar Disorder and Treatment (5 papers). J. Peuskens is often cited by papers focused on Schizophrenia research and treatment (14 papers), Mental Health and Psychiatry (5 papers) and Bipolar Disorder and Treatment (5 papers). J. Peuskens collaborates with scholars based in Belgium, United Kingdom and Netherlands. J. Peuskens's co-authors include C.G.G. Link, Guido Pieters, Jan Knapen, Pascal Sienaert, Davy Vancampfort, H. De Cuyper, Marc Eneman, A. Claus, S. Heylen and J. Bollen and has published in prestigious journals such as The British Journal of Psychiatry, Acta Psychiatrica Scandinavica and Psychiatric Services.

In The Last Decade

J. Peuskens

19 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exercise for the Treatment of Depression

2009 654 citations Jan Knapen, Davy Vancampfort et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Peuskens Belgium	11	1.2k	436	303	274	272	19	1.9k
J. Peuskens Belgium	29	1.7k 1.5×	662 1.5×	298 1.0×	219 0.8×	293 1.1×	87	2.6k
William Montgomery United States	25	1.3k 1.1×	469 1.1×	179 0.6×	331 1.2×	158 0.6×	88	2.3k
Michael J. Sernyak United States	26	1.3k 1.1×	305 0.7×	178 0.6×	219 0.8×	229 0.8×	58	1.9k
Martin Strassnig United States	29	1.5k 1.3×	350 0.8×	431 1.4×	159 0.6×	269 1.0×	64	2.2k
Steven J. Romano United States	21	798 0.7×	490 1.1×	187 0.6×	239 0.9×	116 0.4×	32	1.6k
L.P. Chandler United States	7	1.7k 1.5×	526 1.2×	764 2.5×	346 1.3×	161 0.6×	14	2.7k
Rosa Ayesa‐Arriola Spain	26	1.3k 1.1×	440 1.0×	131 0.4×	186 0.7×	275 1.0×	157	2.1k
Michael D. Lesem United States	16	943 0.8×	704 1.6×	190 0.6×	216 0.8×	147 0.5×	24	2.0k
W.W. Fleischhacker Austria	27	1.5k 1.3×	387 0.9×	217 0.7×	409 1.5×	290 1.1×	58	2.5k
Jayendra K. Patel United States	16	2.0k 1.7×	515 1.2×	174 0.6×	433 1.6×	119 0.4×	22	2.4k

Countries citing papers authored by J. Peuskens

Since Specialization

Citations

This map shows the geographic impact of J. Peuskens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Peuskens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Peuskens more than expected).

Fields of papers citing papers by J. Peuskens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Peuskens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Peuskens. The network helps show where J. Peuskens may publish in the future.

Co-authorship network of co-authors of J. Peuskens

This figure shows the co-authorship network connecting the top 25 collaborators of J. Peuskens. A scholar is included among the top collaborators of J. Peuskens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Peuskens. J. Peuskens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Binder, Marc D., J. Peuskens, Alex J. Mitchell, et al.. (2015). Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatrica Scandinavica. 133(1). 5–22. 71 indexed citations

Demunter, Hella, et al.. (2011). [Clinical assessment of the ultra high risk of developing a a psychotic disorder; review and critical reflection].. PubMed. 53(3). 153–62. 1 indexed citations

Peuskens, J., et al.. (2010). Validité des psychoses fonctionnelles non affectives du DSM IV dans une population congolaise. Une étude clinique transversale. L Encéphale. 37(2). 101–109. 2 indexed citations

Crocq, M.A., Д. Набер, M Lader, et al.. (2010). Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone. European Neuropsychopharmacology. 20(12). 829–838. 19 indexed citations

Peuskens, J., et al.. (2009). Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countries. Current Medical Research and Opinion. 26(3). 501–509. 53 indexed citations

Knapen, Jan, et al.. (2009). Exercise for the Treatment of Depression. 1(1). 78–83. 654 indexed citations breakdown →

Scheen, A J, Marc D. Binder, L. Hanssens, et al.. (2007). P353 - Anomalies de la tolérance au glucose chez les patients schizophrènes traités par antipsychotiques de seconde génération : étude comparative prospective de 3 mois. The World Journal of Biological Psychiatry. 2 indexed citations

Emmerson, Brett, et al.. (2007). PMH40 12-MONTH TREATMENT DISCONTINUATION RATES IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG ACTING INJECTION (RLAI): INTERIM RESULTS FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY PROJECT CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM. Value in Health. 10(3). A83–A83. 1 indexed citations

Peuskens, J., Ján Pečeňák, Lars Eriksson, et al.. (2007). PMH9 TREATMENT RETENTION WITH RISPERIDONE LONG ACTING INJECTION (RLAI) IN EUROPEAN PATIENTS WITH SCHIZOPHRENIA: 12-MONTH INTERIM RESULTS FROM ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY (E-STAR). Value in Health. 10(6). A290–A290. 2 indexed citations

10.

Winkel, Ruud van, Marc D. Binder, D Van Eyck, et al.. (2006). Screening for Diabetes and Other Metabolic Abnormalities in Patients with Schizophrenia and Schizoaffective Disorder: Evaluation of Incidence and Screening Methods. Drug Safety. 29(10). 911–1010. 10 indexed citations

11.

Nayer, André, M. Ansseau, Hugo D’Haenen, et al.. (2002). An eight-week, open-label, uncontrolled, multicenter, Phase IV study of remission rates in outpatients and inpatients with major depression treated with venlafaxine. Current Therapeutic Research. 63(8). 475–485. 3 indexed citations

12.

Peuskens, J.. (1999). The evolving definition of treatment resistance.. PubMed. 60 Suppl 12. 4–8. 41 indexed citations

13.

Peuskens, J. & C.G.G. Link. (1997). A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatrica Scandinavica. 96(4). 265–273. 205 indexed citations

14.

Binder, Marc D., et al.. (1997). Rehabilitation and Resocialization for the Long-Term Mentally III in Belgium: Description of Services and History of Their Development. International Journal of Mental Health. 26(2). 86–97. 5 indexed citations

15.

Peuskens, J.. (1996). Proper psychosocial rehabilitation for stabilised patients with schizophrenia: the role of new therapies. European Neuropsychopharmacology. 6. 7–12. 10 indexed citations

16.

Binder, Marc D., et al.. (1996). Partial hospitalization at night: the Brussels Nighthospital. Psychiatric Services. 47(5). 527–528. 6 indexed citations

17.

Peuskens, J.. (1995). Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol. The British Journal of Psychiatry. 166(6). 712–726. 449 indexed citations

18.

Carman, John Scott, et al.. (1995). Risperidone in the treatment of negative symptoms of schizophrenia. International Clinical Psychopharmacology. 10(4). 207–214. 101 indexed citations

19.

Claus, A., J. Bollen, H. De Cuyper, et al.. (1992). Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study. Acta Psychiatrica Scandinavica. 85(4). 295–305. 251 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact